These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24121179)

  • 1. Cystic hypersecretory (in situ) carcinoma of the breast: a clinicopathologic and immunohistochemical characterization of 10 cases with clinical follow-up.
    D'Alfonso TM; Ginter PS; Liu YF; Shin SJ
    Am J Surg Pathol; 2014 Jan; 38(1):45-53. PubMed ID: 24121179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinicopathologic features of cystic hypersecretory lesion of the breast].
    Bi R; Cheng Y; Yu B; Shui R; Yang W; Xu X
    Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):25-9. PubMed ID: 24713245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic hypersecretory hyperplasia and cystic hypersecretory duct carcinoma of the breast. Pathology, therapy, and follow-up of 39 patients.
    Guerry P; Erlandson RA; Rosen PP
    Cancer; 1988 Apr; 61(8):1611-20. PubMed ID: 2832048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive cystic hypersecretory carcinoma of the breast: a case report.
    Lee JS; Lee YJ
    J Korean Med Sci; 2004 Feb; 19(1):149-51. PubMed ID: 14966360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma.
    Djordjevic B; Malpica A
    Am J Surg Pathol; 2012 Jul; 36(7):955-63. PubMed ID: 22613998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical staining characteristics of low-grade adenosquamous carcinoma of the breast.
    Kawaguchi K; Shin SJ
    Am J Surg Pathol; 2012 Jul; 36(7):1009-20. PubMed ID: 22446941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive cystic hypersecretory carcinoma of the breast: a case report.
    Liu J; Yang W; Wu X; Hu X
    Int J Clin Exp Pathol; 2015; 8(6):7499-502. PubMed ID: 26261660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic hypersecretory carcinoma: rare and poorly recognized variant of intraductal carcinoma of the breast. Report of five cases.
    Skalova A; Ryska A; Kajo K; Di Palma S; Kinkor Z; Michal M
    Histopathology; 2005 Jan; 46(1):43-9. PubMed ID: 15656885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive cystic hypersecretory carcinoma of the breast: a rare variant of breast cancer: a case report and review of the literature.
    Sun J; Wang X; Wang C
    BMC Cancer; 2019 Jan; 19(1):31. PubMed ID: 30621638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast carcinoma in women 35 years and younger: a pathological study.
    Fernandopulle SM; Cher-Siangang P; Tan PH
    Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
    Steinman S; Wang J; Bourne P; Yang Q; Tang P
    Ann Clin Lab Sci; 2007; 37(2):127-34. PubMed ID: 17522367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoma arising from preexisting pregnancy-like and cystic hypersecretory hyperplasia lesions of the breast: a clinicopathologic study of 9 patients.
    Shin SJ; Rosen PP
    Am J Surg Pathol; 2004 Jun; 28(6):789-93. PubMed ID: 15166671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a basal-like subtype of breast ductal carcinoma in situ.
    Livasy CA; Perou CM; Karaca G; Cowan DW; Maia D; Jackson S; Tse CK; Nyante S; Millikan RC
    Hum Pathol; 2007 Feb; 38(2):197-204. PubMed ID: 17234468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathologic study of centrally necrotizing carcinoma of breast].
    Yu L; Yang WT; Cai X; Lu HF; Fan YZ; Shi DR
    Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):657-62. PubMed ID: 20078968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: evidence of a basal-like subset?
    Fadare O; Wang SA; Hileeto D
    Hum Pathol; 2008 Mar; 39(3):331-6. PubMed ID: 18261623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Squamous cell carcinoma in situ of the breast: a light microscopic and immunohistochemical study of a previously undescribed lesion.
    Hayes MM; Peterse JL; Yavuz E; Vischer GH; Eusebi V
    Am J Surg Pathol; 2007 Sep; 31(9):1414-9. PubMed ID: 17721198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic features of ductal carcinoma in situ in young women with an emphasis on molecular subtype.
    VandenBussche CJ; Elwood H; Cimino-Mathews A; Bittar Z; Illei PB; Warzecha HN
    Hum Pathol; 2013 Nov; 44(11):2487-93. PubMed ID: 24029706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ductal carcinoma in situ-like structures in metastatic breast carcinoma.
    Kordek R
    Pathol Res Pract; 2005; 200(11-12):831-4. PubMed ID: 15792128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ductal carcinoma in situ associated with triple negative invasive breast cancer: evidence for a precursor-product relationship.
    Thike AA; Iqbal J; Cheok PY; Tse GM; Tan PH
    J Clin Pathol; 2013 Aug; 66(8):665-70. PubMed ID: 23539741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.